FULC
Price
$10.73
Change
-$0.21 (-1.92%)
Updated
Jan 30 closing price
Capitalization
708.52M
24 days until earnings call
Intraday BUY SELL Signals
ZVRA
Price
$9.00
Change
+$0.14 (+1.58%)
Updated
Jan 30 closing price
Capitalization
507.24M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FULC vs ZVRA

Header iconFULC vs ZVRA Comparison
Open Charts FULC vs ZVRABanner chart's image
Fulcrum Therapeutics
Price$10.73
Change-$0.21 (-1.92%)
Volume$491.88K
Capitalization708.52M
Zevra Therapeutics
Price$9.00
Change+$0.14 (+1.58%)
Volume$716.46K
Capitalization507.24M
FULC vs ZVRA Comparison Chart in %
FULC
Daily Signal:
Gain/Loss:
ZVRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FULC vs. ZVRA commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and ZVRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (FULC: $10.73 vs. ZVRA: $9.00)
Brand notoriety: FULC and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 31% vs. ZVRA: 73%
Market capitalization -- FULC: $708.52M vs. ZVRA: $507.24M
FULC [@Biotechnology] is valued at $708.52M. ZVRA’s [@Biotechnology] market capitalization is $507.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ZVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 4 TA indicator(s) are bullish while ZVRA’s TA Score has 6 bullish TA indicator(s).

  • FULC’s TA Score: 4 bullish, 5 bearish.
  • ZVRA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ZVRA is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а -0.19% price change this week, while ZVRA (@Biotechnology) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +33.81%.

Reported Earning Dates

FULC is expected to report earnings on Feb 26, 2026.

ZVRA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($709M) has a higher market cap than ZVRA($507M). ZVRA YTD gains are higher at: 0.446 vs. FULC (-5.128). ZVRA has higher annual earnings (EBITDA): 67.2M vs. FULC (-80.09M). FULC (201M) and ZVRA (200M) have equal amount of cash in the bank . FULC has less debt than ZVRA: FULC (7.01M) vs ZVRA (62.7M). ZVRA has higher revenues than FULC: ZVRA (84.4M) vs FULC (0).
FULCZVRAFULC / ZVRA
Capitalization709M507M140%
EBITDA-80.09M67.2M-119%
Gain YTD-5.1280.446-1,149%
P/E RatioN/A19.15-
Revenue084.4M-
Total Cash201M200M101%
Total Debt7.01M62.7M11%
FUNDAMENTALS RATINGS
FULC vs ZVRA: Fundamental Ratings
FULC
ZVRA
OUTLOOK RATING
1..100
550
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9626
PRICE GROWTH RATING
1..100
3961
P/E GROWTH RATING
1..100
10051
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (30) in the null industry is somewhat better than the same rating for ZVRA (80). This means that FULC’s stock grew somewhat faster than ZVRA’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as ZVRA (100). This means that FULC’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's SMR Rating (26) in the null industry is significantly better than the same rating for FULC (96). This means that ZVRA’s stock grew significantly faster than FULC’s over the last 12 months.

FULC's Price Growth Rating (39) in the null industry is in the same range as ZVRA (61). This means that FULC’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's P/E Growth Rating (51) in the null industry is somewhat better than the same rating for FULC (100). This means that ZVRA’s stock grew somewhat faster than FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCZVRA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
Bearish Trend 6 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signal:
Gain/Loss:
ZVRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BTMFX23.54N/A
N/A
Boston Trust Midcap
BEQAX35.85-0.19
-0.53%
American Century Equity Growth A
RIGKX17.72-0.20
-1.12%
Victory RS International R
POAGX52.42-1.16
-2.16%
PRIMECAP Odyssey Aggressive Growth
BGGSX27.84-0.64
-2.25%
Baillie Gifford US Equity Growth I

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with WVE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-1.92%
WVE - FULC
55%
Loosely correlated
-0.54%
GPCR - FULC
49%
Loosely correlated
+1.49%
OCUL - FULC
48%
Loosely correlated
-8.14%
SLS - FULC
48%
Loosely correlated
-3.08%
KRRO - FULC
43%
Loosely correlated
+0.15%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with ACLX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
+1.58%
ACLX - ZVRA
38%
Loosely correlated
+0.07%
XERS - ZVRA
37%
Loosely correlated
+1.66%
AUTL - ZVRA
36%
Loosely correlated
-4.20%
FULC - ZVRA
35%
Loosely correlated
-1.92%
IMTX - ZVRA
34%
Loosely correlated
+1.81%
More